Orlando, FL -- (SBWIRE) -- 10/04/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Incyte Corporation (NASDAQ:INCY).
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) shares increased 1.73% to $59.94. Goldman Sachs Group Inc. began coverage on shares of QCOR in a research report sent to investors on Sept. 19. The firm issued a neutral rating and a $65.27 target price on the stock. The analysts noted that the move was a valuation call.
Additionally, QCOR’s Director Virgil Thompson sold 5,000 shares of Questcor Pharmaceuticals stock in a transaction dated September 16th. The stock was sold at an average price of $63.75, for a total value of $318,750.00. Following the completion of the transaction, the director now directly owns 29,867 shares in the company. The sale was disclosed in a document filed with the SEC.
Are investors worried about the recent updates with QCOR? Find out with a free trend analysis HERE
Incyte Corporation (NASDAQ:INCY) shares gained 1.09% to $40.82. The company on Oct. 3 announced results from a 28-day, placebo-controlled, dose-escalation Phase II proof-of-concept clinical trial involving 50 patients with chronic plaque psoriasis for its proprietary oral JAK1 inhibitor, INCB39110. The results were presented by Robert Bissonnette, M.D., President of Innovaderm Research Inc. and co-lead investigator, today at the European Academy of Dermatology and Venereology (EADV) Congress in Istanbul, Turkey.
In the trial, evidence of efficacy was observed in patients treated with INCB39110 at all doses as measured by static physician global assessment (sPGA) and psoriasis area and severity index (PASI) as compared to patients treated with placebo. INCB39110 was generally well-tolerated with no evidence of myelosuppression.
Is INCY going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)